Repetitive enhancement of serum BDNF subsequent to continuation ECT

Continuation electroconvulsive therapy (c‐ECT) is highly effective for the prevention of depressive symptom relapse. There is a lack of understanding, about how c‐ECT works in humans, particularly with regard to its effects on brain derived neurotrophic factor (BDNF) concentrations. Here, we aimed to close a gap in the literature by evaluating BDNF levels in patients receiving c‐ECT.

[1]  G. Kranz,et al.  Acute and subsequent continuation electroconvulsive therapy elevates serum BDNF levels in patients with major depression , 2019, Brain Stimulation.

[2]  M. Chakravarty,et al.  Acute and long-term effects of electroconvulsive therapy on human dentate gyrus , 2019, Neuropsychopharmacology.

[3]  G. M. Godbersen,et al.  Structural changes in amygdala nuclei, hippocampal subfields and cortical thickness following electroconvulsive therapy in treatment-resistant depression: longitudinal analysis , 2018, The British Journal of Psychiatry.

[4]  Anders M. Dale,et al.  Volume of the Human Hippocampus and Clinical Response Following Electroconvulsive Therapy , 2018, Biological Psychiatry.

[5]  D. McLoughlin,et al.  BDNF plasma levels and genotype in depression and the response to electroconvulsive therapy , 2018, Brain Stimulation.

[6]  R. Cho,et al.  Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder , 2018, Scientific Reports.

[7]  C. Andrade,et al.  A Randomized, Nonblind, Naturalistic Comparison of Efficacy and Cognitive Outcomes With Right Unilateral, Bifrontal, and Bitemporal Electroconvulsive Therapy in Schizophrenia , 2017, The journal of ECT.

[8]  N. Wray,et al.  A direct test of the diathesis–stress model for depression , 2017, Molecular Psychiatry.

[9]  M. Friedrich.  Depression Is the Leading Cause of Disability Around the World. , 2017, JAMA.

[10]  E. Castrén,et al.  Neuronal plasticity and neurotrophic factors in drug responses , 2017, Molecular Psychiatry.

[11]  B. Pakkenberg,et al.  Electroconvulsive stimulation results in long‐term survival of newly generated hippocampal neurons in rats , 2017, Hippocampus.

[12]  A. Granholm,et al.  BDNF Responses in Healthy Older Persons to 35 Minutes of Physical Exercise, Cognitive Training, and Mindfulness: Associations with Working Memory Function. , 2016, Journal of Alzheimer's disease : JAD.

[13]  J. Quevedo,et al.  Increased BDNF levels after electroconvulsive therapy in patients with major depressive disorder: A meta-analysis study. , 2016, Journal of psychiatric research.

[14]  Y. Barde,et al.  Brain-derived Neurotrophic Factor in Megakaryocytes*♦ , 2016, The Journal of Biological Chemistry.

[15]  M. Fleck,et al.  Remission of depression following electroconvulsive therapy (ECT) is associated with higher levels of brain-derived neurotrophic factor (BDNF) , 2016, Brain Research Bulletin.

[16]  E. Holsboer-trachsler,et al.  BDNF in sleep, insomnia, and sleep deprivation , 2016, Annals of medicine.

[17]  François-Laurent De Winter,et al.  Relationship Between Hippocampal Volume, Serum BDNF, and Depression Severity Following Electroconvulsive Therapy in Late-Life Depression , 2016, Neuropsychopharmacology.

[18]  E. Tongiorgi,et al.  A method for reproducible measurements of serum BDNF: comparison of the performance of six commercial assays , 2015, Scientific Reports.

[19]  P. Schoenknecht,et al.  Brain-Derived Neurotrophic Factor and Antidepressive Effect of Electroconvulsive Therapy: Systematic Review and Meta-Analyses of the Preclinical and Clinical Literature , 2015, PloS one.

[20]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders. Part 2: Maintenance Treatment of Major Depressive Disorder-Update 2015 , 2015, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[21]  A. Sartorius,et al.  Focus on ECT seizure quality: serum BDNF as a peripheral biomarker in depressed patients , 2015, European Archives of Psychiatry and Clinical Neuroscience.

[22]  A. Brunoni,et al.  BDNF blood levels after electroconvulsive therapy in patients with mood disorders: A systematic review and meta-analysis , 2014, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[23]  S. Kasper,et al.  Neurotransmitters and Electroconvulsive Therapy , 2014, The journal of ECT.

[24]  S. H. Christiansen,et al.  Temporal gene expression profile after acute electroconvulsive stimulation in the rat. , 2014, Gene.

[25]  J. Beck,et al.  High baseline BDNF serum levels and early psychopathological improvement are predictive of treatment outcome in major depression , 2014, Psychopharmacology.

[26]  D. Bartsch,et al.  Genetic fate mapping of type‐1 stem cell‐dependent increase in newborn hippocampal neurons after electroconvulsive seizures , 2013, Hippocampus.

[27]  D. McLoughlin,et al.  Electroconvulsive stimulation alters levels of BDNF-associated microRNAs , 2013, Neuroscience Letters.

[28]  H. Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[29]  L. von Knorring,et al.  Continuation Electroconvulsive Therapy With Pharmacotherapy Versus Pharmacotherapy Alone for Prevention of Relapse of Depression: A Randomized Controlled Trial , 2013, The journal of ECT.

[30]  S. Yamawaki,et al.  Electroconvulsive seizure, but not imipramine, rapidly up-regulates pro-BDNF and t-PA, leading to mature BDNF production, in the rat hippocampus. , 2013, The international journal of neuropsychopharmacology.

[31]  D Winkler,et al.  Global decrease of serotonin-1A receptor binding after electroconvulsive therapy in major depression measured by PET , 2012, Molecular Psychiatry.

[32]  D. McLoughlin,et al.  Systematic review and meta-analysis of bifrontal electroconvulsive therapy versus bilateral and unilateral electroconvulsive therapy in depression , 2012, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[33]  K. Rabheru.  Maintenance Electroconvulsive Therapy (M-ECT) After Acute Response: Examining the Evidence for Who, What, When, and How? , 2012, The journal of ECT.

[34]  E. Tongiorgi,et al.  Physical Exercise and Antidepressants Enhance BDNF Targeting in Hippocampal CA3 Dendrites: Further Evidence of a Spatial Code for BDNF Splice Variants , 2012, Neuropsychopharmacology.

[35]  B. Franke,et al.  Serum brain-derived neurotrophic factor: Determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people , 2011, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[36]  G. Petrides,et al.  Continuation and Maintenance Electroconvulsive Therapy for Mood Disorders: Review of the Literature , 2011, Neuropsychobiology.

[37]  G. Knudsen,et al.  Blood BDNF concentrations reflect brain-tissue BDNF levels across species. , 2011, The international journal of neuropsychopharmacology.

[38]  J. Buitelaar,et al.  Determinants of serum brain-derived neurotrophic factor , 2011, Psychoneuroendocrinology.

[39]  T. Si,et al.  The Level of Serum Brain-Derived Neurotrophic Factor Is Associated With the Therapeutic Efficacy of Modified Electroconvulsive Therapy in Chinese Patients With Depression , 2010, The journal of ECT.

[40]  E. Castrén,et al.  The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity , 2010, Developmental neurobiology.

[41]  A. Sartorius,et al.  Correlations and Discrepancies between Serum and Brain Tissue Levels of Neurotrophins after Electroconvulsive Treatment in Rats , 2009, Pharmacopsychiatry.

[42]  Henriette Pilegaard,et al.  Evidence for a release of brain‐derived neurotrophic factor from the brain during exercise , 2009, Experimental physiology.

[43]  R. Duman,et al.  Serum Brain-Derived Neurotrophic Factor, Depression, and Antidepressant Medications: Meta-Analyses and Implications , 2008, Biological Psychiatry.

[44]  H. Odeberg,et al.  Individualized Continuation Electroconvulsive Therapy and Medication as a Bridge to Relapse Prevention After an Index Course of Electroconvulsive Therapy in Severe Mood Disorders: A Naturalistic 3-Year Cohort Study , 2008, The journal of ECT.

[45]  H. Sackeim,et al.  Neurobiological Correlates of the Cognitive Side Effects of Electroconvulsive Therapy , 2008, The journal of ECT.

[46]  H. Möller,et al.  Electroconvulsive therapy and its different indications , 2008, Dialogues in clinical neuroscience.

[47]  P. Pasqualetti,et al.  Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients , 2006, European Neuropsychopharmacology.

[48]  A. Scott,et al.  Electroconvulsive therapy in depressive illness that has not responded to drug treatment. , 2004, Journal of affective disorders.

[49]  P. Stang,et al.  Response, partial response, and nonresponse in primary care treatment of depression. , 2004, Archives of internal medicine.

[50]  R. Duman.  Neural plasticity: consequences of stress and actions of antidepressant treatment , 2004, Dialogues in clinical neuroscience.

[51]  W. Pardridge,et al.  Transport of Human Recombinant Brain-Derived Neurotrophic Factor (BDNF) Through the Rat Blood−Brain Barrier in Vivo Using Vector-Mediated Peptide Drug Delivery , 1994, Pharmaceutical Research.

[52]  M. Schwald,et al.  Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets , 2002, Neuroscience Letters.

[53]  R. Duman,et al.  Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression , 2002, The Journal of Neuroscience.

[54]  S. Kasper,et al.  Einsatz der Elektrokrampftherapie in der Psychiatrie , 2001, Der Nervenarzt.

[55]  M. Thase,et al.  Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial. , 2001, JAMA.

[56]  R. Frey,et al.  [Use of electroconvulsive therapy in psychiatry]. , 2001, Der Nervenarzt.

[57]  William A Banks,et al.  Transport of brain-derived neurotrophic factor across the blood–brain barrier , 1998, Neuropharmacology.